Long-term treatment of Parkinson's disease with bromocriptine.

BRomocriptine (15-75 mg per day) alone or with L-dopa was studied during five to 29 months on 44 patients with Parkinson's disease. Used as sole therapeutic agent, it was found excellent in 12 patients who had never received regular L-dopa treatment either because it was never attempted or because o...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Neurol Neurosurg Psychiatry
Autori principali:	Rascol, A, Guiraud, B, Montastruc, J L, David, J, Clanet, M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 1979
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490179/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/422961/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.42.2.143
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!